No shared counterparties.
| Stage | CAT | % of rev | AEBI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $20.7B | 100.00% | $496M | 100.00% | CAT ×41.66 |
| Gross profit | $7.3B | 35.54% | $97M | 19.60% | CAT +15.9pp |
| Operating income | $4.2B | 20.38% | $27M | 5.45% | CAT +14.9pp |
| Pre-tax income | $4.2B | 20.40% | $15M | 3.09% | CAT +17.3pp |
| Net income | $3.3B | 15.89% | $10M | 2.11% | CAT +13.8pp |
| Stage | CAT | AEBI | Gap · A − B |
|---|---|---|---|
| Revenue | $20.7B100.00% | $496M100.00% | CAT ×41.66 |
| Gross profit | 35.54%$7.3B | 19.60%$97M | CAT +15.9pp |
| Operating income | 20.38%$4.2B | 5.45%$27M | CAT +14.9pp |
| Pre-tax income | 20.40%$4.2B | 3.09%$15M | CAT +17.3pp |
| Net income | 15.89%$3.3B | 2.11%$10M | CAT +13.8pp |